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Abstract Monocyte-chemoattractant protein-1 (MCP-1), al-
so known as CCL2, is a potent chemoattractant of T cells and
monocytes, involved in inflammatory and angio-proliferative
brain and retinal diseases. Higher expression of MCP-1 is
observed in metastatic tumors. Unusual levels of MCP-1 in
the brain may be correlated with autism. Immunochemistry
where atomic force microscope (AFM) tips functionalized
with appropriate antibodies against MCP-1 are used could in
principle support medical diagnostics. Useful signals from
single molecule experiments may be generated if interaction
forces are large enough. The chemokine-antibody unbinding
force depends on a relativemotion of the interacting fragments
of the complex. In this paper the stability of the medically
important MCP-1- immunoglobulin G antibody Fab fragment
complex has been studied using steered molecular dynamics
(SMD) computer simulations with the aim to model possible
arrangements of nano-diagnostics experiments. Using SMD
we confirm that molecular recognition in MCP1-IgG is based
mainly on six pairs of residues: Glu39A - Arg98H, Lys56A -
Asp52H, Asp65A - Arg32L, Asp68A - Arg32L, Thr32A -
Glu55L, Gln61A - Tyr33H. The minimum external force
required for mechanical dissociation of the complex depends
on a direction of the force. The pulling of the MCP-1 antigen
in the directions parallel to the antigen-antibody contact plane
requires forces about 20 %–40 % lower than in the perpen-
dicular one. Fortunately, these values are large enough that the
fast lateral force spectroscopy may be used for effective nano-
diagnostics purposes. We show that molecular modeling is a
useful tool in planning AFM force spectroscopy experiments.
Keywords Atomic force microscopy . Bionanomechanics .
IgG antibody .Monocyte-chemoatractant protein-1 . Steered
molecular dynamics
Introduction
The immune system (IS) is a complex network of body organs
providing means for defense against pathogens and
maintaining integrity of the organism [1]. Due to its medical
significance, especially in the contexts of allergies and cancer
immunotherapy, IS is vigorously studied [2]. However, our
understanding of IS, especially on amolecular level, is still not
satisfactory. Recent years brought discoveries of new roles of
signaling proteins involved in IS activity modulating the brain
[3]. Here we investigate interactions of a small protein MCP-1
which has a diagnostic potential in diseases related to the
central nervous system (CNS) and cancer.
Monocyte chemoattractant protein-1 (MCP-1), also known
as chemokine ligand 2 (CCL2), is a member of the chemokine
family [4]. The chemokines are a type of cytokines, they are
divided into two main groups, based on a relative position of
the conserved cysteines, which can be either adjacent (CC
type) or separated by one amino acid (CXC chemokines). The
basic function of those cytokines is to act on chemoattraction
in traffic regulation of immune cells. MCP-1 consists of 77
amino acids and belongs to the CC subfamily [5]. It binds to
CCR2 and CCR4 receptors [6] but interacts strongly with
specialized antibodies as well. MCP-1 is a chemoattrator to
monocytes, memory Tcells, and dendritic cells [7, 8]. Its main
function is to recruit those immune cells to a place of infection
or injury. Over a thousand of experimental papers on MCP-1
have been published since its discovery in 1989 [9, 10].
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Recent studies show that MCP-1 is also expressed in
astrocytes, microglia and neurons [11, 12]. Receptors of
MCP-1 are present on surfaces of those CNS cells. The
presence of MCP-1 causes migration of leukocytes into the
CNS. MCP-1 is present in CNS not only in inflammation but
also in the healthy brain [4]. Thus, this chemokine can mod-
ulate activity of neurons, astrocytes and microglia [3].
MCP-1 may play a role in many diseases, including multi-
ple sclerosis, rheumatoid arthritis, atherosclerosis, obesity and
insulin-resistant diabetes [13]. It has a direct role in angiogen-
esis and tumor progression [14], promotes prostate cancer
tumorigensis and metastasis [15]. The first studies on humans
of a new drug CNTO888 (monoclonal antibody) blocking
MCP-1 has been very recently published [16]. Other recent
studies show that it may also be involved in autism spectrum
disorder (ASD) [17–19]. The level of MCP-1 in brain tissues
and cerebrospinal fluid [17] in autistic subjects is higher than
that in healthy people. Levels of MCP-1 in plasma of children
with ASD is elevated [18] as well. Those facts may suggest that
the neuroimmune response is a part of the neuropathological
processes in ASD and that MCP-1 may play a pathogenic role
in this disorder [19] and prompted us to undertake this study.
Atomic force microscopy (AFM) has been proposed as a
useful tool for studies of molecular recognition processes [20,
21]. Protein-antibody interactions may be studied using clas-
sical contact mode techniques [22–24]. In these methods the
antibody is attached to a silanized tip and a vertical force
exerted by the AFM cantilever tip dissociates transient
antibody-protein complexes [25, 26]. The maximum force
registered during withdrawing the cantilever from the surface
covered with a sample, is a measure of the interaction between
antibody and protein. The AFM techniques have been suc-
cessfully used in other antigen-IgG studies [27, 28] but these
are very time-consuming procedures. TheMCP-1 IgG complex
has not been studied experimentally, yet. An alternative, prom-
ising in the nano-diagnostics, technique is friction (or lateral)
force spectroscopy (FFS) [29, 30]. In contrast to the standard
contact mode AFM, in FFS the probe quickly scans the surface
laterally and the “unbinding” is enforced by the lateral forces.
Usually the AFM tip is functionalized by the antibody and a
protein is immobilized on a surface. The process of the
enforced dissociation (molecular recognition) may depend on
a relative orientation/motion of both proteins. Forces too weak
do not generate useful signals.
In order to compare intermolecular interactions met in a
classical AFM recognition experiment and in the lateral ar-
rangement, we set-up a computer model of such an experiment.
The impact of the direction of the AFM tip motion on mechan-
ically enforced dissociation of antigen—antibody complex was
computationally studied. Simulations of MCP-1 in a complex
with the Fab fragment of immunoglobulin IgG antibody were
performed using the Steered Molecular Dynamics method
(SMD) [31–33]. This “virtual experiment” approach has been
successful in studies of proteins’ nanomechanics [34–36]. Our
numerous SMD ns scale trajectories revealed new atomic
details of the molecular recognition phenomena in that medi-
cally important system. We show that the lateral dissociation
requires substantially (20–40 %) lower forces than the vertical
uncoupling of the complex but the later forces are still high
enough to make FFS in our system feasible. This finding
indicates that after careful calibration of friction based AFM
methods a routine FFS nano-diagnostics involving MCP-1
chemokine will be possible.
Methods
As the first step we studied dynamics of a complex of human
MCP-1 with 11 K2 Fab fragment [6] (Fig. 1) using the molec-
ular dynamic (MD) method [37]. 11 K2 is a mouse monoclonal
antibody against several humanMCPs. The complex, extracted
from the 2BDN entry in the Protein Data Bank was embedded
in an 8 Å thick TIP3P water shell. After 0.4 ns equilibration we
performed 10 ns of main MD simulation, using the NAMD 2.7
code [38] and the CHARMM27 force field [39].
Next, the SMD [31, 32] method was used in order to apply
an external force which should dissociate the MCP-1-antibody
complex in two perpendicular directions: the „vertical” force
(V, almost parallel to the main axis of the antibody, the
direction „z“ in Fig. 1) and the „lateral” one (L, approximately
perpendicular to the main axis of the antibody). An increasing
external virtual force was attached to all CA atoms of MCP-1
(chain A). During the simulations of stretching all CA atoms of
Fig. 1 A schematic view of MCP-1 (blue) and Fab fragment of Ig G
antibody complex. In red light chains (L) are shown, in gray heavy chains
(A) are depicted. V denotes variable region of IgG. Yellow arrows represent
directions of virtual forces used in simulations. An orange arrow is an
example of V direction and a green one represents L direction Note that
direction of the z axis was used to define spherical coordinates of force vectors
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the antibody (chains L and H) were fixed. The last structures
obtained from the 3 ns standard MD simulations served as
starting points for all SMD simulations. Structures were pulled
for 2 ns at a constant speed of 0.025 Å/ps with a spring constant
of 278 pN/Å. This value is close to that used in typical FFS
experiments. Twenty two pulling directions were used. In addi-
tionwe have studied a role of disulfide bridges on thismolecular
recognition process: two 2 ns simulations for each direction
were generated for systems with all disulfide bridges converted
to cysteines. Thus 3×9 V trajectories, and 3×13 L trajectories
(Fig. 1) were further analyzed. Moreover, for one selected,
representative V direction and one L direction ten additional
trajectories (2 ns each) were generated in order to calculate
values of an average dissociation force and to estimate statisti-
cal errors in the maximum force determination. Additionally, a
dependence of the calculated forces on the pulling speed was
tested. For ten directions, five vertical (V) and five lateral ones
(L), we generated trajectories with a constant speed of
0.0025 Å/ps, i.e., ten times slower than before.
Electrostatic molecular potentials were calculated using the
APBS method [40–43].
The analysis of results was performed using the VMD code
[44] and homemade scripts.
Results and discussion
A classical MD
SinceMCP-1 chemokine, despite its medical significance, has
not been previously analyzed using classical MD modeling,
we have studied dynamics of the complex on a 10 ns time-
scale. Except for the flexible terminal ends the chemokine has
a rigid structure. Mean square atomic displacements of amino
acids with respect to average positions (B-factor simulation)
correlate rather well with the temperature B factors (Fig. 2).
As expected, the N-terminal end (Ala4-Thr10) exhibit very
large flexibility. This region is responsible for dimerization of
MCP-1 cytokine [45]. One may notice that in the Cys12 –
Ile32 fragment the model is more stable than X-ray measure-
ments indicate. Probably in the computer model of an isolated
complex the Arg18 residue is more strongly stabilized by the
intramolecular electrostatic interactions than in a crystal set-
ting. Both the simulations and the X-ray experiment indicate
that the most stable region is Ala40 – Thr45 which corre-
sponds to β2 internal β stand. Amino acids identified in the
SMD simulations as being involved in molecular recognition
process (Thr32, Glu39, Lys56, Gln61, Asp65) exhibit low
fluctuations as well. This means that the MCP-1/IgG interface
is quite well stabilized. The calculated B-factors for the Fab
fragment are also in a very good agreement with the experi-
mental data [6], Fig. 3.
In Fig. 3 one can see that the most flexible part of the
antibody heavy chain corresponds to a large loop in the region
from Ala128(H) to Ser138(H). Interestingly, also in the anti-
body we observe a polar region which is more stable in the
simulations than in a real crystal: Glu175-Ser176-Asp177. We
explain this stabilization by a relaxation in an isolated model
complex which leads to new salt bridges. Probably such
relaxation is absent in the crystal due to packing interactions.
Steered molecular dynamics—mechanically enforced
dissociation
All calculated force spectra of the enforced dissociation of
MCP1-Fab complexes show qualitatively the same features—
(i) a steep rise of the force up to a certain maximum value, (ii)
a gradual decrease of the interaction force (iii) a separation
phase characterized by a force close to 1 nN corresponding to
the hydrodynamic drag. Representative curves for L and V
dissociation modes are shown in Fig. 4. All calculated maxi-
ma of unbinding forces are collected in Table 1.
Fig. 2 A comparison of calculated mean square atomic displacements of
MCP-1 cytokine amino acidswith experimental temperature B-factors [6]
Fig. 3 A comparison of calculated mean square atomic displacements of
heavy chain of Fab IgG antibody fragment with experimental temperature
B-factors [6]
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In reducing chemical conditions S-S protein bridges may
break apart, ditiothreitol is commonly used for that purpose.
Also some enzymes, such as thioredoxin or glutaredoxin facil-
itate transfer of electrons and make this redox reaction possi-
ble. Another source of the absence of stabilizing S-S covalent
bondsmay be just a point mutation in a cysteine position. Such
perturbation may have significant impact on the molecular
recognition process, particularly in CC chemokines. In order
to check how such a structural modification may affect
“in vitro” AFM experiments, we have repeated SMD simula-
tion for models in which S-S bridges were disrupted both in
MCP-1 chemokine and in the IgG antibody Fab fragment (7
bridges in total are absent now). Results for the reduced forms
of the complex are presented in Table 1 as well (First, Second).
Thus, in total 69 output files were analyzed for the value of
the force necessary to dissociate the complex.
Fig. 4 Examples of SMD
calculated force spectra for
unbinding process. Typical plots
of values of the force in two
selected directions: V vertical, L
lateral for a 2 ns simulations and
b 10 ns simulations (10× slower
pulling speed than in 2 ns
simulations)
Table 1 Maximum values of force (in pN) obtained in each 2 ns SMD
simulation and in ten simulations with pulling speed ten times slower
(slower10×). Varying direction vectors of the pulling force close to the
vertical one (z axis of the molecular complex, Fig. 1) are designed as Vi,
more lateral vectors are designed by Li. Data for three series of
trajectories, for MCP-1 with (SS present) and without disulfide bridges
present (First, Second) are shown in columns. Average values of calcu-
lated maximum forces (average) are presented for each set together with
standard deviations of each averaged maximum force
Direction vector V SS_present First Second L SS_present First Second
V1 2102 1791 2213 L11 1522 1856 2001
V2 2911 2342 1943 L12 2045 1958 1497
V3 2678 1989 2448 L13 1668 1622 1877
V4 2663 2195 2215 L14 1391 1551 1511
V5 2084 2264 2294 L15 1859 1760 1548
V6 1768 1961 1671 L16 1737 2330 2293
V7 2537 2418 2208 L17 2148 1859 2001
V8 2152 2293 2239 L18 1988 2170 1959
V10 2776 2611 2431 L19 2229 2003 2033
V5v2 2161 2423 2323 L20 1606 1798 1604
V5v3 2214 2061 2294 L21 1472 1608 1556
V5v4 1907 2067 2178 L22 2224 2076 2127
V5v5 1974 2345 2259 L23 1493 1856 2255
Average 2302 2212 2209 Average 1799 1880 1866
Standard deviation 366 228 204 Standard deviation 301 227 289
V2 slower10x 1591 L14 slower10x 905
V7 slower10x 1259 L20 slower10x 829
V10 slower10x 1515 L21 slower10x 793
V5 slower10x 1097 L13 slower10x 1159
V8 slower10x 1723 L15 slower10x 1124
Average 1437 Average 962
Standard deviation 254 Standard deviation 169
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In the standard forms (S-S bonds present), for 2 ns simula-
tions, when the vertical (V) direction of the pulling force
vector was applied, the lowest calculated force value was
1768 pN, while the highest value was 2911 pN. The average
value of the maximum force observed during V direction
SMD simulation was 2302±366 pN. For laterally oriented
pulling vectors the forces were lower: the highest value was
2229 pN, the lowest was 1391 pN, the average 1799±301 pN.
Respectively, for the simulations with ten times slower pulling
speed the average for the vertical forces was 1437±254 pN,
and for the lateral force simulations the average was 962±169
pN. Thus the process of mechanical unbinding requires lower
forces if it proceeds in the direction L parallel to the MCP-1-
antibody contact plane.
To study possible correlations between the value of the force
necessary to separate antibody and MPC-1 and the dragging
force direction we transformed force vectors into standard
spherical coordinates (see Fig. 1). Forces with respect to values
of the φ angle (only for “lateral” L cases) are given in Fig. 5a
and forces dependence on the θ angle are shown in Fig. 5b.
Data presented in Fig. 5 clearly show that for the purely
vertical separations the process requires the highest forces. In
more lateral directions some lower force paths for dissociation
may be easily found. The average later force is 22 % (2 ns
simulations) and 40 % (for ten times slower pulling speed)
lower than the vertical one. One should remember, that the
SMD calculated forces, even with the low pulling speed, are a
factor of 8–10 higher than those usually measured in AFM FS
experiments. The reason is that, due to limited computer power,
the loading rate used in SMD calculations has to be typically
much higher than that in an experiment. However, calculated
SMD forces correctly reproduce experimental trends: the lower
the pulling speed—the lower the force. The simulations with ten
times lower velocities confirm, that there is a difference in
maximum unbinding forces for V and L arrangements of the
dissociating components of the complex. Given all difficulties
related to quantitative reproduction of force spectra from the
Fig. 5 Plots showing the dependence of maximum values of the forces
for every simulation on the pulling force vector orientation—in spherical
coordinates φ (a) and θ (b). Only shorter 2 ns trajectories are shown
Fig. 6 An interface between MCP-1 and Fab IgG at the maximum force
(V5) of SMD simulation. Amino acids involved in double interactions are
shown in ball-and-stick representation. Thr32A-Glu55L pair is shown in
orange, Glu39A- Arg98H pair is shown in green, Gln61A-Tyr33H pair is
shown in pink . Standard coloring of atoms was applied for residues
interacting with two amino acids from the partner protein. An important
Phe101 residue is also shown in gray
Fig. 7 Maps of electrostatic potential projected on solvent accessible
surfaces ofMCP-1 and Fab fragment of IgG [40–44]. Positive regions are
colored in blue, negative—in red . Complementary regions a, b and c are
schematically indicated. Phe101H is shown in green
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virtual SMD experiments, we conclude that lateral motion of the
functionalized AFM tip may require less force than a standard
(V) contact mode molecular recognition study. These findings
await for experimental confirmation, so far no AFM experi-
ments for this system have been performed yet.
Molecular recognition and bioinformatics analysis of MCP-1
Detailed analysis of trajectories gave unique information on
molecular interactions between the antibody and MCP-1 and
their evolutions along alternative stretching paths. The flat
interface region in a static crystal has been previously charac-
terized [6]: it consists of the end ofβ1 strand, theβ1–β2 loop,
the beginning of β2 strand, the loop between β3 and α1, and
the α1 helix. The formation of the complex buries about 15 %
of the MCP-1 solvent accessible surface. Most of the contacts
with MCP-1 are made through complementarity determining
regions (CDR) H1 and H3 of the heavy chain of IgG and
CDRs L1 and L3 of the light chain [6]. Important for recog-
nition is Phe101H residue embedded in a mainly hydrophobic
pocket of MCP-1 composed of Arg30A, Thr32A, Glu39A,
Val41A, Pro55A and Met64A.
During stretching we observe that the complex is stabilized
by strong salt bridges (in bold) and hydrogen bonds between:
Glu39A - Arg98H , Lys56A - Asp52H , Asp65A - Arg32L ,
Asp68A - Arg32L , Thr32A - Glu55L, Gln61A - Tyr33H,
where A denotes MCP-1, L - a light chain of IgG Fab frag-
ment and H—the heavy chain of Fab. These interactions are
shown in Fig. 6. Enlisted salt bridges/H-bonds were present in
the majority of analyzed trajectories prior to an enforced
dissociation both in Vand L subsets. However, the scenario
of consecutive breaking of these bonds obviously depends
on the direction of the dragging force, particularly for L
type vectors. Our trajectories provide data for interpretation
of fine details induced by local events in future AFM force
spectra.
Reduction of cysteines does not affect this list of stronger
intermolecular interactions in MCP-1/Fab complex. Inter-
estingly, additional H-bonds interacting pairs Asp68A-
Ile31L, Lys56A-Trp32H were observed only for the complex
with S-S bonds present.
Besides perfect matching of VdW surfaces and a strong
hydrophobic handle created by Phe101, electrostatic interac-
tions may also play a significant role for long range recogni-
tion in this system. We have used APBS program [40–43] to
calculate a map of the molecular electrostatic potential (MEP)
of MCP-1 and the Fab fragment. Rigid separated structures
extracted from the 2BDN data were used for calculations.
Results are presented in Fig. 7.
There are at least three regions (a, b, c, Fig. 7) with higher
values of MEP. The regions in MCP-1 have corresponding
counterparts in the Fab system of opposite charge. Thus
electrostatics contribute to the stability of this complex as
well. These calculations help to identify regions crucial for
effective recognition of the important MCP-1 chemokine.
The fragment of MCP-1 specifically recognized by an
antibody is called epitope. In order to check to what extent
amino acids present at the interface in our cytokine are con-
served in other proteins we performed PSI-BLAST search in
standard non-redundant protein sequences database and used
ClustalX2 code [46, 47] to make alignments of ten most
similar sequences. Results visualized with Jalview 2.7 pro-
gram [48, 49] are presented in Fig. 8.
For proteins in this set over 80 % similarity to MCP-1 is
observed. Amino acids important for strong interactions iden-
tified by SMD simulations were analyzed in greater detail.
Two distinct groups of polar epitope amino acids are present
in MCP-1: conserved set (Thr32, Glu39, Gln61, Asp68) and a
specific set: Lys56 and Asp65. In the conserved set the same
amino acids are present in nearly all similar proteins. Residues
from the specific set are characteristic only for MCP-1 che-
mokine. This finding corresponds well with the observed 160-
fold decrease of IgG antibody affinity to a Lys56Asn MCP-1
mutant described in [6]. Thus Lys56 and Asp65 are particu-
larly strongly involved in specific recognition of this chemo-
kine by our IgG antibody. It is worth noting that this region is
distinct from that responsible for an interaction ofMCP-1 with
its natural membrane receptor. Mutational studies have
Fig. 8 Alignment of MCP-1 sequence with ten most similar proteins showing conserved residues. Black rectangles in MCP-1 sequence denote
Lys56(A) and Asp65(A) residues critical for specific molecular recognition with the antibody
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shown, that only a small subset of surface residues of human
MCP-1 is important for effective interaction with CCR2 re-
ceptor: Tyr13, Arg24, Lys38, Lys49 [50]. None of these
residues is involved in interaction with Fab fragment of IgG
antibody studied here.
Conclusions
The presented computer modeling study was intended to check
whether the lateral FFS AFM approach using antibody func-
tionalized tips can be used in antigen-antibody molecular rec-
ognition studies and nano-diagnostics involving chemokines.
Our results of over forty 2 ns and ten 10 ns long SMD simu-
lations have shown that the interaction force between the Fab
fragment of IgG antibody and MCP-1 is significant in lateral
unbinding, thus such measurements should be possible.
Computer experiments indicate that irrespective of a particular
direction of the lateral unbinding forces, their values are sys-
tematically lower by about 20-40 % than the vertical ones. Ten
times lower pulling speed data confirm qualitatively this con-
clusion. The lower forces require better sensitivity in the exper-
iments than a standard, time consuming tapping modes, if FFS
technique is to be used in the nano-diagnostics. This may be
achieved by careful selection of high affinity antibodies against
MCP-1 or a better design of the AFM hardware. The SMD
force required to dissociate the complex studied here was even
bigger than the force required to unfold the whole contactin 4
protein calculated with the same SMD protocol [51].
The strong intermolecular interactions arise from a set of 4–6
strong salt bridges and hydrogen bonds.MEPmaps based of the
CHARMM force field for MCP-1 and the antibody show high
degree of electrical complementarity. Substantial hydrophobic
interactions of Phe101 IgG residue, also noticed earlier [6],
contribute to the molecular recognition process as well. Recent
synthesis of human MCP-1 using a combination of solid phase
peptide synthesis and native chemical ligation further enhances
potential for medical applications of this interesting protein [52].
In summary, our modeling results indicate that the AFM
FFS diagnostics using antibody functionalized tips for fast
lateral scanning of a sample with immobilized cytokine may
be a promising alternative to time consuming classical AFM
measurements.
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